Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1759-1768

  Bodey, Bela ^a,e   Bodey Jr , Bela ^a   Siegel, Stuart E ^b   Kaiser, Hans E ^c,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VIENNA   (Austria)

^e NONE   (United States)

Author keywords

Angiogenesis; Cytotoxic T lymphocytes (CTL); Extracellular matrix (ECM); Granulocytes; Immunocytochemistry; Immunophenotype (IP); Macrophages; Monoclonal antibodies (MoABs); Natural killer (NK) cells; Tumor infiltrating leukocytes (TIL); Tumor progression and metastasis

Indexed keywords

ALKALINE PHOSPHATASE; CD45 ANTIGEN; CD8 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; GRANULOCYTE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKOCYTE; MACROPHAGE; MEDULLOBLASTOMA; MELANOMA; NATURAL KILLER CELL; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EXTRACELLULAR MATRIX; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0033854935     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Chin Y, Janseens J, Vandepitte J, Vandenbrande J, Opdeheek L, Raus J: Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 12: 1463-1466, 1992.
2. Dietl J, Horny HP, Ruck P, Kaiserling E: Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphorelicularcells and tumor cells. Cancer 71: 2562-2568, 1993.
3. Finke JH, Rayman P, Hart L, Alexander JP, Edinger MG, Tubbs RR, Klein E, Tuason L, Bokowski RM: Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J Immunother Emph Tumor Immunol 15: 91-104, 1994.
4. Maccalli C, Mortarini R, Parmiani G, Anichini A: Multiple sub-sets of CD4+ and CDS+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Int J Cancer 57: 56-62, 1994.
5. Bodey B, Bodey B Jr, Siegel SE: Immunophenotypic characterization of infiltrating poly- and mononuclear cells in childhood brain tumors. Mod Pathol 8: 333-338, 1995.
6. Bodey B, Bodey B Jr, Siegel SE, Luck JV, Kaiser HE: Immunophenotypic characterization of human primary and metastatic melanoma infiltrating autologous immunological effector cells. Anticancer Res 16: 3439-3446, 1996.
7. Halapi E: Oligoclonal T cells in human cancer. Med Oncol 15: 203-211, 1998.
8. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M: Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27: 407-414, 1998.
9. Vracko R: Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 77: 314-338, 1974.
10. Timpl R, Fujiwara S, Dziadek M, Aumailley M, Weber S, Engel J: Laminin, proteoglycan, nidogen and collagen IV: structural models and molecular interactions. Ciba Found Symp 108: 25-43, 1984.
11. Chung AE, Durkin ME: Entactin: structure and function. Am J Respir Cell Mol Biol 3: 275-82, 1990.
12. Yurchenco PD: Assembly of laminin and type IV collagen in to basement membrane networks. In: Extracellular matrix assembly and structure (Yurchenco PD. Birk DE, Mecham RP, eds). San Diego: Academic Press, 1994.
13. Kadler K: Extracellular matrix. 1. Fibril-forming collagens. Protein Profile 1: 519-638, 1994.
14. Timpl R, Dziadek M: Structure, development, and molecular pathology of basement membranes. Int Rev Exp Pathol 29: 1-112, 1986.
15. Siegal GP, Barsky SH, Terranova VP, Liotta LA: Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. An immunoperoxidase study. Invasion Metastasis 1: 54-70, 1981.
16. Hayman EG, Oldberg A, Martin GR, Ruoslahti E: Codistribution of heparan sulfate proteoglycan, laminin, and fibronectin in the extracellular matrix of normal rat kidney cells and their coordinate absence in transformed cells. J Cell Biol 94: 28-35, 1982.
17. Barsky SH, Siegal GP, Jannotta F, Liotta LA: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140-147, 1983.
18. Farmilo AJ, Stead RH: Fixation in immunocytochemistry. In: Handbook Immunochemical Staining Methods, Ed. Naish S.J., DAKO Corporation. 1989, pp. 24-29.
19. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison of ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29: 577-581, 1981.
20. Janckila AJ, Yam LT, Li C-Y: Immunoalkaline phosphatase cytochemistry. Amer J Clin Pathol 84: 476-480, 1985.
21. Cattoretti G, Berti E, Schiro R, D'Amato L, Valeggio C, Rilke F: Improved avidin-biotin peroxidase complex (ABC) staining. Histochem J 20: 75-80, 1988.
22. Bodey B, Zeltzer PM, Saldivar V, Kemshead J: Immunophenotyping of childhood astrocytomas with a library of monoclonal antibodies. Int J Cancer 45: 1074-1087, 1990.
23. Yam LT, Janckila AJ, Epremian BE, Li C-Y: Diagnostic significance of levamisole-resistant alkaline phosphatase in cytochemistry and immunocytochemistry. Amer J Clin Pathol 91: 31-36, 1989.
24. Perentes E, Rubinstein LJ: Non-specific binding of mouse myeloma IgM immunoglobulins by human myelin sheetes and astrocytes. Acta Neuropathol 70: 284-288, 1986.
25. Strasburger CJ, Amir-Zaltsman Y, Kohen F: The avidin-biotin reaction as an universal amplification system in imnumoassays. Prog Clin Biol Res 285: 79-100, 1988.
26. Wilchek M, Bayer EA: Introduction to avidin-biotin technology. Methods Enzymol 184: 5-13, 1990.
27. Duhamel RC, Whitehead JS: Prevention of nonspecific binding of avidin. Methods Enzymol 184: 201-207, 1990.
28. Diamandis EP, Christopoulos TK: The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem 37: 625-636, 1991.
29. Shi S-R,. Key ME, Kalra KL: Antigen retrieval in formalin fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
30. Shi S-R, Cote C, Kalra K.L, Taylor CR, Tandon AK: A technique for retrieving antigens in formalin-fixed, routinely acid-decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry. J Histochem Cytochem 40: 787-792, 1992.
31. thor Straten P, Becker JC, Guldberg P, Zeuthen J: In situ T cells in melanoma. Cancer Immunol Immunother 48: 386-395, 1999.
32. Elder D: Tumor progression, early diagnosis and prognosis of melanoma. Acta Oncol 38: 535-547, 1999.
33. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA, Moreno M: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79: 2320-2328, 1997.
34. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58: 3491-3494, 1998.
35. Trieb K, Lechleitner T, Lang S, Windhager R, Kotz R, Dirnhofer S: Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma. Pathol Res Pract 194: 679-684, 1998.
36. Menard S, Tomasic G, Casalini P, Balsari A, Pilotti S, Cascinelli N, Salvadori B, Colnaghi MI, Rilke F: Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res 3: 817-819, 1997.
37. Cardone A, Tolino A, Zarcone R, Borruto Caracciolo G, Tartaglia E: Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med 39: 174-177, 1997.
38. Hartveit F: Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report. Oncol Rep 5: 423-426, 1998.
39. Stevens A, Kloter I, Roggendorf W: Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 61: 738-743, 1988.
40. Kuppner MC, Hamou MF, de Tribolet N: Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas. Cancer Res 48: 6926-6932, 1988.
41. Zhang BX: Ohsevation on the phenotypic changes of tumor-infiltrating lymphocytes (TIL) during cultivation in vitro. Chinese J Pathol 21: 281-283, 1992.
42. Shilyansky J, Nishimura MI, Yannelli JR, Kawakami Y, Jacknin LS, Charmley P, Rosenberg SA: T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc Natl Acad Sci USA 91: 2829-2833, 1994.
43. Schrier PI, Bernards R, Vaessen RTMJ, Houweling A, van der Eb AJ: Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 3115: 771-775, 1983.
44. Becker JC, Termeer C, Schmidt RE, Brocker EB: Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol 151: 7224-7232, 1943.
45. Walker RA, Dearing SJ, Gallacher B: Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 69: 1160-1165, 1994.
46. Mule JJ, Schwarz SL, Roberts AB, Sporn MB, Rosenberg SA: Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother 26: 95-100, 1988.
47. Sporn MB, Roberts AB, Wakefield LM, Assoian RK: Transforming growth factor-beta: biological function and chemical structure. Science 233: 532-534, 1986.
48. Rivoltini L, Arienti F, Orazi A, Cefalo G, Gasparini M, Gambacorti-Passerini C, Fossati-Bellani F, Parmiano G: Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype. Cancer Immunol Immunother 34: 241-251, 1942.
49. Applegate KG, Balch CM, Pellis NR: In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes. Cancer Res 50: 7153-7158, 1990.
50. Gorski A, Castronovo V, Stepien-Sopniewska B, Grieb P, Ryba M, Mrowiec T, Korczak-Kowalska G, Wierzbicki P, Matysiak W, Dybowska B: Depressed immune surveillance against cancer: role of deficient T cell:extracellular matrix interactions. Cell Adhes Commun 2: 225-233, 1994.
51. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z: Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12: 112-27, 1992.
52. Jiang WG: Membrane ruffling of cancer cells: a parameter of tumour cell motility and invasion. Eur J Surg Oncol 21: 307-309, 1995.
53. Dabbous MK, North SM, Haney L, Tipton DA, Nicolson GL: Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis 13: 33-41, 1995.
54. Gregoire M, Lieubeau B: The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 14: 339-350, 1995.
55. McGary CT, Pan YC, Michel H, Guntrum WD, Neri A, Welch DR: Elevated expression of the neutrophil calcium-binding protein, MRP-14, in metastasis-enhancing neutrophils. Anticancer Res 17: 1-6, 1997.
56. Welch DR, Schissel DJ, Howrey RP, Aeed PA: Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci USA 86: 5859-5863, 1989.
57. Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ: Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898, 1990.
58. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R: Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307-3312, 1988.
59. Sloane BF, Honn KV: Cysteine proteinases and metastasis. Cancer Metastasis Rev 3: 249-263, 1984.
60. Liotta LA: Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci USA 76: 2268-2272, 1979.